WeChat Mini Program
Old Version Features

603 Phase II Trial of Plinabulin in Combination with Nivolumab and Ipilimumab in Patients with Recurrent Small Cell Lung Cancer (SCLC): Big Ten Cancer Research Consortium (BTCRC-LUN17–127) Study

Jyoti Malhotra,Alberto Chiappori,Salma K Jabbour,Chunxia Chen,Naomi Fujioka,Nasser H Hanna,Lawrence E Feldman,Malini Patel,Dirk Moore

Journal for ImmunoTherapy of Cancer（2023）

Cited 0|Views21
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined